Improved Outcomes with Linezolid for Methicillin-Resistant Staphylococcus aureus Infections: Better Drug or Reduced Vancomycin Susceptibility?

Lignende værker

• Reduced Vancomycin Susceptibility in Staphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications
  af: Howden, Benjamin P., et al.
  Udgivet: (2010)
• 1588. Delafloxacin Activity Against Staphylococcus aureus with Reduced Susceptibility or Resistance to Methicillin, Vancomycin, Daptomycin, or Linezolid
  af: Saravolatz, Louis D, et al.
  Udgivet: (2019)
• Prospective Comparison of the Clinical Impacts of Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus (MRSA) and Vancomycin-Susceptible MRSA
  af: Horne, K. C., et al.
  Udgivet: (2009)
• Methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility in Taiwan
  af: Lin, Chien-Yu, et al.
  Udgivet: (2018)
• Methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility in Taiwan
  af: Chien-Yu Lin, et al.
  Udgivet: (2018-01-01)